Avitas Wealth Management LLC Uro Gen Pharma Ltd. Transaction History

Avitas Wealth Management LLC

  • $651 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 23, 2019
SELL
$32.75 - $40.35 $387,006 - $476,815
-11,817 Closed
0 $0
Q1 2019

May 01, 2019
SELL
$35.47 - $54.55 $25,290 - $38,894
-713 Reduced 5.69%
11,817 $437,000
Q4 2018

Feb 08, 2019
BUY
$38.35 - $50.39 $480,525 - $631,386
12,530 New
12,530 $540,000

Others Institutions Holding URGN

# of Institutions
113
Shares Held
24M
Call Options Held
46.9K
Put Options Held
44.3K
View Full List

About UroGen Pharma Ltd.

URGN Quotes by TradingView
  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $373M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Avitas Wealth Management LLC Portfolio

Follow Avitas Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avitas Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email